Summary

Chugai Pharmaceutical Co., Ltd. - Company Profile and SWOT Analysis

Summary

Chugai Pharmaceutical Co., Ltd. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Chugai Pharmaceutical Co., Ltd. (Chugai or 'the company') is involved in bio pharmaceutical research and development. The company offers medical products and services for the human health. Chugai produces antibody drugs that focus on oncology, renal diseases, immunology and infectious diseases and bone and joint diseases. The company’s product portfolio includes Actemra (tocilizumab), Alfarol, Avastin (bevacizumab), Bonviva (ibandronate), CellCept (mycophenolate mofetil), Tamiflu (oseltamivir phosphate), Edirol (eldecalcitol), Kadcyla (trastuzumab emtansine), Kytril, and Mircera (epoetin beta pegol). Chugai operates and markets its products in North America, Europe and Asia. The company is headquartered in Tokyo, Japan.

Scope

- Detailed information on Chugai Pharmaceutical Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Chugai Pharmaceutical Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Chugai Pharmaceutical Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on Chugai Pharmaceutical Co., Ltd.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Chugai Pharmaceutical Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Chugai Pharmaceutical Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Chugai Pharmaceutical Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Chugai Pharmaceutical Co., Ltd.'s business structure, strategy and prospects.

ページTOPに戻る

Table of Contents

Table of Contents
Company Snapshot
Chugai Pharmaceutical Co., Ltd.: Company Overview
Chugai Pharmaceutical Co., Ltd.: Overview and Key Facts
Chugai Pharmaceutical Co., Ltd.: Overview
Chugai Pharmaceutical Co., Ltd.: Key Facts
Chugai Pharmaceutical Co., Ltd.: Key Employees
Chugai Pharmaceutical Co., Ltd.: Key Employee Biographies
Chugai Pharmaceutical Co., Ltd.: Major Products and Services
Chugai Pharmaceutical Co., Ltd.: Management Statement
Chugai Pharmaceutical Co., Ltd.: Locations and Subsidiaries
Chugai Pharmaceutical Co., Ltd.: Key Competitors
Chugai Pharmaceutical Co., Ltd.: Company Analysis
Chugai Pharmaceutical Co., Ltd.: Business Description
Chugai Pharmaceutical Co., Ltd.: SWOT Analysis
Chugai Pharmaceutical Co., Ltd.: SWOT Overview
Chugai Pharmaceutical Co., Ltd.: Strengths
Chugai Pharmaceutical Co., Ltd.: Weaknesses
Chugai Pharmaceutical Co., Ltd.: Opportunities
Chugai Pharmaceutical Co., Ltd.: Threats
Chugai Pharmaceutical Co., Ltd.: Corporate Financial Deals Activity
Chugai Pharmaceutical Co., Ltd.: Financial Deals Overview
Chugai Pharmaceutical Co., Ltd.: Targets and Partners
Chugai Pharmaceutical Co., Ltd.: Top Deals 2019 - 2023YTD*
Chugai Pharmaceutical Co., Ltd.: Partnership
Chugai Pharmaceutical Co., Ltd.: Divestments
Chugai Pharmaceutical Co., Ltd.: Recent Developments
Chugai Pharmaceutical Co., Ltd.: News and Events Summary
Chugai Pharmaceutical Co., Ltd.: Business Expansion
Chugai Pharmaceutical Co., Ltd.: Business Reorganization
Chugai Pharmaceutical Co., Ltd.: Corporate Governance
Chugai Pharmaceutical Co., Ltd.: Financial Performance
Chugai Pharmaceutical Co., Ltd.: Research & Development
Chugai Pharmaceutical Co., Ltd.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine